Gene · 10577
Papers2,338
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,338
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Knowledge graphs facilitate prediction of drug response for acute myeloid leukemia. | iScience | 2024 | 39280607 | PubTator, text mining | PubMed |
| Axial Crushing and Energy Absorption Integrated Design of Modular Filled Double-Hat Beam Composite Structures. | Materials (Basel) | 2024 | 39274691 | PubTator, text mining | PubMed |
| Advances in research on potential therapeutic approaches for Niemann-Pick C1 disease. | Front Pharmacol | 2024 | 39263569 | PubTator, text mining | PubMed |
| Body composition trajectories during childhood predict skeletal maturation at puberty: A longitudinal study. | Heliyon | 2024 | 39253277 | PubTator, text mining | PubMed |
| Clinical presentation and molecular genetics of Iranian patients with Niemann-pick type C disease and report of 6 NPC1 gene novel variants: A case series. | Mol Genet Metab Rep | 2024 | 39185019 | PubTator, text mining | PubMed |
| The role of NPC2 gene in glioma was investigated based on bioinformatics analysis. | Sci Rep | 2024 | 39160329 | PubTator, text mining | PubMed |
| The Proteomic Landscape of Monocytes in Response to Colorectal Cancer Cells. | J Proteome Res | 2024 | 39106312 | PubTator, text mining | PubMed |
| Efficient breeding system of infertile Niemann-Pick disease type C model mice by in vitro fertilization and embryo transfer. | Lab Anim | 2024 | 39102515 | PubTator, text mining | PubMed |
| Evaluation of the landscape of pharmacodynamic biomarkers in Niemann-Pick Disease Type C (NPC). | Orphanet J Rare Dis | 2024 | 39061081 | PubTator, text mining | PubMed |
| CRISPR/Cas9 technology in the modeling of and evaluation of possible treatments for Niemann-Pick C. | Mol Biol Rep | 2024 | 39033258 | PubTator, text mining | PubMed |
| Stoichiometry and architecture of the human pyruvate dehydrogenase complex. | Sci Adv | 2024 | 39018392 | PubTator, text mining | PubMed |
| A rare case of Niemann Pick Disease with a novel variant in the NPC2 gene presenting with neuropsychiatric manifestations in middle age. | Asian J Psychiatr | 2024 | 38838476 | PubTator, text mining | PubMed |
| The Aging Lacrimal Gland of Female C57BL/6J Mice Exhibits Multinucleate Macrophage Infiltration Associated With Lipid Dysregulation. | Invest Ophthalmol Vis Sci | 2024 | 38829671 | PubTator, text mining | PubMed |
| A Rare Case of Niemann-Pick Disease Type-A. | Cureus | 2024 | 38826605 | PubTator, text mining | PubMed |
| Bioinformatics Analysis Reveals Prognostic Significance of the Macrophage Marker Gene Signature in Gastric Adenocarcinoma. | Front Biosci (Landmark Ed) | 2024 | 38812299 | PubTator, text mining | PubMed |
| Elevated Bile Acid 3β,5α,6β-Trihydroxycholanoyl Glycine in a Subset of Adult Ataxias Including Niemann-Pick Type C. | Antioxidants (Basel) | 2024 | 38790666 | PubTator, text mining | PubMed |
| Overview of clinical, molecular, and therapeutic features of Niemann-Pick disease (types A, B, and C): Focus on therapeutic approaches. | Cell Biochem Funct | 2024 | 38715125 | PubTator, text mining | PubMed |
| Deciphering the heterogeneity dominated by tumor-associated macrophages for survival prognostication and prediction of immunotherapy response in lung adenocarcinoma. | Sci Rep | 2024 | 38653742 | PubTator, text mining | PubMed |
| Importance of the biochemical investigations for the functional characterization of a NPC1 variant identified by exome sequencing. | Am J Med Genet A | 2024 | 38549495 | PubTator, text mining | PubMed |
| Functional Characterization of the Niemann-Pick C2 Protein BdioNPC2b in the Parasitic Wasp Baryscapus dioryctriae (Chalcidodea: Eulophidae). | J Agric Food Chem | 2024 | 38546111 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10577/papers?page=7